Date and time
This session will provide an overview of current treatment pathways for child ADHD, including first-line pharmacological options, non-stimulant alternatives, titration considerations, side-effect management and the role of behavioural and environmental interventions. The discussion will also explore shared-care arrangements, communication with primary care, and supporting families in informed decision-making.
Designed to strengthen clinical confidence and clarity in prescribing pathways, this session will offer practical insight for professionals involved in assessment, treatment and ongoing care of children with ADHD.
A live Q&A will follow the presentations.
- NHS and private GPs
- Primary Care Clinicians
- Paediatricians and Child & Adolescent Psychiatrists
- Practice Nurses, ANPs and Physician Associates
- Mental health practitioners working within CAMHS or PCNs
- Clinicians involved in ADHD assessment, prescribing or shared-care
- Education professionals supporting children with ADHD
- Parents and members of the wider public seeking to understand treatment pathways
Organised by
















